Back to search results

Ontario-wide Cancer TArgeted Nucleic Acid Evaluation

Abroad (travel likely)Recruiting

Conditions

Breast Cancer · Lung Cancer · Colorectal Cancer · Melanoma · Gynecological Cancer · Genitourinary Cancer · Pancreatobiliary Cancer · Gastrointestinal Cancer · Head and Neck Cancer · Rare Cancer · Unknown Primary Cancer

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • Juravinski Cancer Centre, Hamilton, Ontario, Canada

  • Kingston General Hospital, Kingston, Ontario, Canada

  • London Health Sciences Centre, London, Ontario, Canada

  • The Ottawa Hospital Cancer Centre, Ottawa, Ontario, Canada

    Contact: Study coordinator (Han (Jenny) Zhang) · hanzhang@ohri.ca · 613-737-7700
    Contact: Study coordinator (Kendra Christink) · kchristink@toh.ca · 613-737-7700
    Contact: Principal Investigator (John Hilton, MD)

  • Princess Margaret Hospital, Toronto, Ontario, Canada

    Contact: Study coordinator (Samanta Del Rossi) · samanta.delrossi@uhn.ca · 416-946-4501
    Contact: Principal Investigator (Philippe Bedard, MD)
    Contact: Principal Investigator (Lillian Siu, MD)

  • Mount Sinai Hospital, Toronto, Ontario, Canada

  • Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada

Study leads

  • Philippe Bedard, MD

    Principal Investigator

    Princess Margaret Hospital, Canada

  • Lillian Siu, MD

    Principal Investigator

    Princess Margaret Hospital, Canada

View source on ClinicalTrials.gov(opens in a new tab)